药品评价
藥品評價
약품평개
DRUG REEVALUATION
2013年
2期
30-31
,共2页
中药注射剂%销售金额%用药频度%日均费用
中藥註射劑%銷售金額%用藥頻度%日均費用
중약주사제%소수금액%용약빈도%일균비용
Traditional Chinese Medicine Injections%Utilization Analysis%Consumption Sum%DDDs%DDC
目的:了解我院心脑血管病类中药注射剂的使用情况,为临床合理用药提供参考.方法:对我院2007~2011年心脑血管病类中药注射剂的销售金额、用药频度(DDDs)、日均费用(DDC)等进行统计分析.结果:在加强使用管理前(即2007~2010年),心脑血管病类中药注射剂年销售金额和占全院药品总销售金额比例呈上升趋势,在2011年各类中药注射剂的上述2项指标均下降.临床对注射用丹参、注射用血栓通的选择倾向性较大,丹红注射液的DDC相对较高.结论:在加强中药注射剂使用管理后,我院心脑血管病类中药注射剂的使用趋向合理.
目的:瞭解我院心腦血管病類中藥註射劑的使用情況,為臨床閤理用藥提供參攷.方法:對我院2007~2011年心腦血管病類中藥註射劑的銷售金額、用藥頻度(DDDs)、日均費用(DDC)等進行統計分析.結果:在加彊使用管理前(即2007~2010年),心腦血管病類中藥註射劑年銷售金額和佔全院藥品總銷售金額比例呈上升趨勢,在2011年各類中藥註射劑的上述2項指標均下降.臨床對註射用丹參、註射用血栓通的選擇傾嚮性較大,丹紅註射液的DDC相對較高.結論:在加彊中藥註射劑使用管理後,我院心腦血管病類中藥註射劑的使用趨嚮閤理.
목적:료해아원심뇌혈관병류중약주사제적사용정황,위림상합리용약제공삼고.방법:대아원2007~2011년심뇌혈관병류중약주사제적소수금액、용약빈도(DDDs)、일균비용(DDC)등진행통계분석.결과:재가강사용관리전(즉2007~2010년),심뇌혈관병류중약주사제년소수금액화점전원약품총소수금액비례정상승추세,재2011년각류중약주사제적상술2항지표균하강.림상대주사용단삼、주사용혈전통적선택경향성교대,단홍주사액적DDC상대교고.결론:재가강중약주사제사용관리후,아원심뇌혈관병류중약주사제적사용추향합리.
0bjective:To analyze the clinical use of Traditional Chinese Medicine injections for treating heart and cerebral disease in our hospital and provide reference for their rational use.Methods: The drugs used in our hospital from 2007 to 2011 were analyzed in respect of consumption sum, DDDs and DDDc.Results:This kind of drugs were predominantly used,and the annual consumption sum of traditional Chinese medicine injections increased year by year from 2007 to 2010,until 2011, during which the management of traditional Chinese injection was strengthen, showed a decreasing trend. In this 5 years, clinical demand for Danshen injection, Xueshuantong injection is higher, while Danhong injection has a relatively high DDC. Conclusion:After strengthen the use and management of traditional Chinese medicine injection, the use of this kind of drug shows a reasonable trend.
